| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | Chief Executive Officer | Director
2 companies
Weis Holger is a Director at JUNS, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $37K at current prices.
Weis Holger's largest disclosed position is in TCRT as CEO, worth about $37K. Net of sales, the recent Form 4 record there shows accumulation of 50,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2021 | TCRT Alaunos Therapeutics, Inc. | Director | Buy | 50,000 | $1.83 | $91,500.00 | +71.3% | -22.3% | +68.2% |